AXIM® Biotechnologies Develops Next Generation of its Rapid Neutralizing Antibody Test for COVID-19

NEXT STORY
Vaxil Announces Progress on Research and Development Activities
PREV STORY
Quotient Limited Announces Appointment of Chief Financial Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

HOOKIPA Pharma Announces Proposed Public Offering of Common Stock and Preferred Stock

author_avatar
NASDAQ Market News

SELLAS Announces Positive Follow-Up Phase 1/2 Clinical Data for Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)

author_avatar
NASDAQ Market News

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE “TRANSPARENCY LAW”)

REGULATED INFORMATION GHENT, Belgium, 26 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] ...

author_avatar
NASDAQ Market News